# Nikolaos Fragakis

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/nikolaos-fragakis/

## Facts

| Field | Value |
| --- | --- |
| Citations | 486 |
| Field | Diabetes Treatment and Management |
| h-index | 11 |
| i10-index | 12 |
| Last Known Institution | Aristotle University of Thessaloniki |
| OpenAlex ID | https://openalex.org/A5113187798 |
| Works | 28 |

## Researcher papers

- [Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: Systematic review and network meta-analysis](https://scholariq.org/papers/effect-of-glucagon-like-peptide-1-receptor-agonists-and-co-agonists-on-body/)
- [Prognostic value of stress hyperglycemia ratio in patients with acute myocardial infarction: A systematic review with Bayesian and frequentist meta-analysis](https://scholariq.org/papers/prognostic-value-of-stress-hyperglycemia-ratio-in-patients-with-acute-myocardial/)
- [Vascular Alterations Following COVID-19 Infection: A Comprehensive Literature Review](https://scholariq.org/papers/vascular-alterations-following-covid-19-infection-a-comprehensive-literature/)
- [Therapeutic Potential of Sodium-glucose Co-transporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists for Patients with Acute Coronary Syndrome: A Review of Clinical Evidence](https://scholariq.org/papers/therapeutic-potential-of-sodium-glucose-co-transporter-2-inhibitors-and-glucagon/)
- [Mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: a systematic review and network meta-analysis of 32 randomized trials](https://scholariq.org/papers/mineralocorticoid-receptor-antagonists-in-heart-failure-with-reduced-ejection/)
- [Artificial intelligence-based mining of electronic health record data to accelerate the digital transformation of the national cardiovascular ecosystem: design protocol of the CardioMining study](https://scholariq.org/papers/artificial-intelligence-based-mining-of-electronic-health-record-data-to/)
- [Effect of GLP-1 receptor agonists and co-agonists on atrial fibrillation risk in overweight or obesity: systematic review and meta-analysis of randomized controlled trials](https://scholariq.org/papers/effect-of-glp-1-receptor-agonists-and-co-agonists-on-atrial-fibrillation-risk-in/)
- [SGLT2 inhibitors and cardiac fibrosis: A comprehensive review](https://scholariq.org/papers/sglt2-inhibitors-and-cardiac-fibrosis-a-comprehensive-review/)
- [Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors combination therapy versus monotherapy and major adverse cardiovascular events: Do the benefits add up?](https://scholariq.org/papers/glucagon-like-peptide-1-receptor-agonists-and-sodium-glucose-cotransporter-2/)
- [Intracoronary Thrombolysis in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: an Updated Meta-analysis of Randomized Controlled Trials](https://scholariq.org/papers/intracoronary-thrombolysis-in-st-segment-elevation-myocardial-infarction/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)

## Researcher university

- [Aristotle University of Thessaloniki](https://scholariq.org/institutions/aristotle-university-of-thessaloniki/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.